HOME > TOP STORIES
TOP STORIES
-
BUSINESS MTPC to Dissolve Capital Alliance with Choseido
October 22, 2012
-
REGULATORY Sales Tax Hike Expected to Hasten Separation of Dispensing from Medical Practice by Sapping Yakka-Saeki
October 19, 2012
-
REGULATORY PAFSC Committee Recommends Approval for Switch OTC Version of Epadel 2 Years after Frist Review
October 18, 2012
-
BUSINESS Qol’s Mr Takada Hints at Continued Use of Long-Listed Drugs from Makers Hiring Apo Plus MRs
October 17, 2012
-
BUSINESS MTPC’s Oral MS Treatment Charging towards Blockbuster Territory
October 16, 2012
-
BUSINESS Towa Pharmaceutical Expanding Direct-Sales Network as Its Distributors Face Lack of Successors
October 15, 2012
-
ACADEMIA We Would Like to Provide iPS Cells with Medical History Identification: Prof. Yamanaka of Kyoto University
October 15, 2012
-
BUSINESS Radical AD Treatments Hit “PIII Wall” Again, but Amyloid β Hypothesis Remains Unshaken
October 15, 2012
-
REGULATORY MHLW to Begin Pilot Study on Drug Risk Management Plans for Generics
October 12, 2012
-
ORGANIZATION Price Gap between Long-Listed Products, Generics Necessary: FPMAJ Chairman Naito
October 11, 2012
-
BUSINESS Lack of Patient Satisfaction with BPH Treatments Offers Opportunity; Can Kissei Get Them to Switch to Urief?
October 11, 2012
-
BUSINESS Biz Entertainment Spending by MRs Falls at Most Companies, Down 80% at Foreign Firm: Jiho Poll
October 10, 2012
-
ORGANIZATION Life Science Budget in Japan Lacks Absolute Amount: JPMA President Teshirogi
October 10, 2012
-
REGULATORY Dr Takenaka Tapped as NIBIO Advisor, Committed to Creation of Drug Discovery Network
October 9, 2012
-
BUSINESS GSK’s Requip CR Tablets More Economical and Effective; Sales May Decrease despite Investment in Improved Formulation
October 8, 2012
-
BUSINESS Novartis to See Tasigna Sales More than Double, Value of Glivec Maximized
October 5, 2012
-
REGULATORY Senior Vice Minister Sakurai Calls for Industry-Growth Perspective on Long-Listed Drug Pricing
October 4, 2012
-
REGULATORY MHLW to Enhance Drug Review System to Eliminate Application Lag: PFSB Director Gen. Ebata
October 3, 2012
-
REGULATORY Pharmacist Mitsui Becomes Health Minister, Industry Hails Appointment
October 2, 2012
-
BUSINESS Daiichi Sankyo, AZ to Step Up Promotion for Nexium upon Lifting of Long-Term Prescription Ban
October 1, 2012
ページ
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
